+49 30 648 35 164 service@chameleon-pharma.com

Poland

Pictures of traditionnal colorful houses in Warsaw

Featured image: Photo by Maksym Harbar on Unsplash

Poland: an interesting OTC and pharma market next to Germany 

Poland’s self-medication and pharma market underwent changes in the past few years, putting them on the map of European markets full of opportunities.  

Pharmaceutical exports, especially to Western Europe, have been strong and on the rise, as local producers have increased their focus on more advanced-medicine markets in the last few years. Poland’s consumer healthcare and pharma market value reached USD 8,9 billion in 2021, ex-factory, and is expected to reach USD 18,42 billion by 2035, according to Chameleon Pharma Consulting Group forecasts.

Reforms over the last 10 years have led to a more mature and transparent environment in healthcare. Major changes were introduced in the pricing and reimbursement system, with the goal of increasing transparency, reducing drug spending, and providing higher access to innovations. 

Chameleon Pharma Consulting Group has devel­oped a sys­tem­atic part­ner search process that can iden­tify the most suit­able local part­ner for you in Poland in only 10-12 weeks. Simply contact us for more details !

Poland OTC and pharma market in 2035

USD 18,42 Billion

OTC and pharma market size, ex-factory

4-6%

OTC and pharma market growth

Poland in numbers

Total population

Male/Female

Population growth

Birth rate

Mortality rate

Life expectancy

Interested in this market?

We are ready to support you in Strategy, Marketing, Systematic International Company Partner Identification, Commercial Due Diligence, Business Development, Acquisition Search, Regulatory projects, and more in order to ensure your growth.